ABSTRACT
b-blockers are a heterogeneous class, with individual agents distinguished by selectivity for b1- vs. b2-and a-adrenoceptors, presence or absence of partial agonist activity at one of more b-receptor subtype, presence or absence of additional vasodilatory properties, and lipophilicity...
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.